Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat. - Pan C; Wu QV; Voutsinas J; Houlton JJ; Barber B; Futran N; Laramore GE; Liao JJ; Parvathaneni U; Martins RG; Fromm JR; Rodriguez CP (Head & neck, 2023)